TrialThe Journal of infectious diseases2014

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).

Lindsey R Baden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.